Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04100252
Other study ID # 2018/0480
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 1, 2018
Est. completion date September 1, 2019

Study information

Verified date September 2019
Source Istanbul Medeniyet University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Pregnant women who admitted with the complaint of amniotic fluid leakage between the gestational ages of 23+0 and 33+0 and who finally were diagnosed as PPROM were included in the study. Women with multiple gestations, cervical dilatation above 6 cm at the admission, hypertensive diseases, cervical cerclage, fetal anomalies, olgohydramnios, polihydramnios, and those who declined to involve in the study were excluded.

In all included women were examined at the admission for amniotic fluid index via trans abdominal ultrasonography. AFI were measured by four quadrant technique, which is sum of the deepest vertical length of pocket of fluid in each quadrant without any umbilical cord. All included patients were assessed in two groups; women with AFI<5 and those with AFI≥5 cm.

Included patients were followed in terms of maternal and fetal complications. Maternal complications were chorioamnionitis, placental abruption, placental retention, postpartum endometritis, postpartum hemorrhage; while fetal complications comprised necessity of admission to neonatal intensive care unit, neonatal sepsis, meconium aspiration syndrome, respiratory distress syndrome, intraventricular hemorrhage, umbilical cord pH below 7.10, APGAR score of 5th minute below 5. All complication rates were compared between the groups. In addition, the time period between the diagnosis of PPROM and the time of delivery was defined as latency period and were compared between the groups.


Description:

Pregnant women who admitted with the complaint of amniotic fluid leakage between the gestational ages of 23+0 and 33+0 were examined for the inclusion criteria of the study. Among them, women with usual history of gross amniotic fluid leakage as well as classical speculum findings of ROM, such as pooling of amnitotic fluid within the posterior fornix or vaginal wall, were diagnosed as PPROM and included in the study without any further investigation. In case of the absence of these findings and suspected cases, PPROM was diagnosed via placental alpha-microglobulin-1 test from the vaginal fluid. Those with positive test results were included in the study. Women with multiple gestations, cervical dilatation above 6 cm at the admission, hypertensive diseases, cervical cerclage, fetal anomalies, olgohydramnios, polihydramnios, and those who declined to involve in the study were excluded.

In all included women were examined at the admission for amniotic fluid index via trans abdominal ultrasonography. AFI were measured by four quadrant technique, which is sum of the deepest vertical length of pocket of fluid in each quadrant without any umbilical cord. All included patients were assessed in two groups; women with AFI<5 and those with AFI≥5 cm.

Included patients were followed in terms of maternal and fetal complications. Maternal complications were chorioamnionitis, placental abruption, placental retention, postpartum endometritis, postpartum hemorrhage; while fetal complications comprised necessity of admission to neonatal intensive care unit, neonatal sepsis, meconium aspiration syndrome, respiratory distress syndrome, intraventricular hemorrhage, umbilical cord pH below 7.10, APGAR score of 5th minute below 5. All complication rates were compared between the groups. In addition, the time period between the diagnosis of PPROM and the time of delivery was defined as latency period and were compared between the groups.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date September 1, 2019
Est. primary completion date September 1, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

Pregnant women Diagnosis of PPROM between 23+0 and 33+0 gestational ages. -

Exclusion Criteria:

Multiple gestations, C Cervical dilatation above 6 cm at the admission, Hypertensive diseases, Cervical cerclage, Fetal anomalies, Oligohydramnios, Polihydramnios, Those who declined to participate in the study.

-

Study Design


Related Conditions & MeSH terms


Intervention

Other:
AFI via transabdominal ultrasonography
AFI via transabdominal ultrasonography was performed at the time of diagnosis.

Locations

Country Name City State
Turkey Istanbul Medeniyet University, Goztepe Research and Training Hospital Istanbul Kadikoy

Sponsors (1)

Lead Sponsor Collaborator
Istanbul Medeniyet University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Pregnant Women experiencing Complications Adverse events emerging in included pregnant women from the time of PPROM diagnosis to the end of the postpartum 1st month Through study completion, an average of 1 year
Primary Number of fetuses and newborns experiencing complications Adverse events emerging in fetuses and neonates from the time of PPROM diagnosis to the end of the postpartum 1st month Through study completion, an average of 1 year
Secondary Latency Time The time period from the PPROM diagnosis to delivery. Through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT04478942 - PROMMO Trial: Oral Misoprostol vs IV Oxytocin Early Phase 1
Recruiting NCT02819570 - Comparison of Two Antibiotic Prophylactic Protocols in Preterm Premature Rupture of the Membranes Phase 4
Withdrawn NCT03172858 - Randomized Control Trial of Intracervical Balloon Placement vs Oxytocin in Women With Term PROM and Unripe Cervices N/A
Not yet recruiting NCT05134688 - Magnesium Sulphate in Premature Rupture of Membranes Early Phase 1
Not yet recruiting NCT03689062 - Premature Rupture of Membranes at 34 to 37 Weeks' Gestation N/A
Recruiting NCT06273891 - Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes Phase 3
Recruiting NCT04237142 - Preterm Premature Rupture of Fetal Membranes: Cervical Ultrasound and Biological Markers to Diagnose Prematurity (RECHOBIOL) N/A
Recruiting NCT04558996 - Spanish Registry of Pregnant Women With COVID-19
Recruiting NCT04632017 - Computerized Cardiotocography Monitoring of Fetuses With pPROM
Recruiting NCT03607929 - HIDRATA Study: Efficacy of a Hydration Protocol in Nulliparous Women During Labor N/A
Completed NCT03491826 - Fetal and Maternal Outcome in Preterm Premature Rupture of Membranes (PPROM)
Enrolling by invitation NCT04451109 - Dilapan-S®: A Multicenter US E-registry
Recruiting NCT04143685 - Labor Induction With Misoprostol Versus Oxytocin in Women With Premature Rupture of Membranes N/A
Completed NCT03251898 - Correlation Between Premature Rupture of Membranes and Early-onset Neonatal Infections
Completed NCT03106311 - The Use of Quantitative Pregnancy Test in Amniotic Fluid as a Diagnostic Tool for Rupture of Fetal Membranes N/A